(PDF:395KB)
This case study introduces an interview with Professor Akimichi Morita (Nagoya City University), the developer of Excimer Light. The case study also includes example of Excimer Light implementation.
The newly developed Excimer Filter (patent pending) has passed precise cell testing and clinical evaluation. The filter retains maximum efficacy and safety.
【Application】
Vitiligo/Psoriasis/Palmoplantar pustulosis
Atopic dermatitis/Alopecia areata
|
This case study introduces an interview with Professor Akimichi Morita (Nagoya City University), the developer of Excimer Light. The case study also includes example of Excimer Light implementation. |
|
UVB is a double-edged sword. Depending on the protocol, risk may be increased or ideal efficacy would be retained for refractory skin disease.
TheraBeam UV 308 is equipped with a newly developed Excimer Filter (patent pending) which has passed precise cell testing and clinical evaluation.
Ensuring safety is our first priority.
When beginning from systemic treatment and then moving to treatment of localized reoccurrence and rashes remain only in certain areas, TheraBeam UV 308 offers targeted phototherapy for additional treatment.
The excimer light prevents excessive irradiation of healthy skin areas and enables pinpoint irradiation on affected areas.
A 308 nm excimer light dedicated filter that maximizes efficacy and safety (See the figure below for more information).
Doctors simply prescribed the irradiation amount.
The irradiation amount is then entered by a nurse at the operation panel.
After aligning the position with area for irradiation, the nurse simply presses the “Irradiation Start Button”.
Optimal UV rays for the patients are realized by the newly developed 308 nm Excimer Light and Excimer Filter.